Establishment Labs Holdings (ESTA) FCF Margin (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly FCF Margin came in at 10.29% in Q1 2026, up 3998.0% year-on-year from 0.25% in Q1 2025, and down 263.69% quarter-over-quarter from 6.29% in Q4 2025.
Establishment Labs Holdings (ESTA) FCF Margin (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' FCF Margin history runs 10 years deep, the most recent figure standing at 10.29% for Q1 2026.
- On a quarterly basis, FCF Margin rose 3998.0% year-over-year to 10.29% in Q1 2026; TTM through Mar 2026 was 15.79%, a 2372.0% increase from a year earlier, with the FY2025 full-year figure at 24.11%, up 1259.0% from the prior year.
- FCF Margin slipped to 10.29% in Q1 2026 per ESTA's latest filing, from 6.29% in the prior quarter.
- Across five years, FCF Margin topped out at 6.29% in Q4 2025 and bottomed at 78.04% in Q3 2023.
- The 5-year median for FCF Margin is 39.47% (2024), against an average of 38.66%.
- Across the five-year window, FCF Margin tumbled 4143 bps in 2023 and soared 4578 bps in 2025, its largest moves.
- Year by year, FCF Margin stood at 32.43% in 2022, then sank by 128 bps to 73.86% in 2023, then soared by 47 bps to 39.49% in 2024, then soared by 116 bps to 6.29% in 2025, then sank by 264 bps to 10.29% in 2026.
- Per Business Quant, the three latest ESTA FCF Margin figures stand at 10.29% (Q1 2026), 6.29% (Q4 2025), and 24.35% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | -10.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.29% |
| Dec 31, 2025 | 6.29% |
| Sep 30, 2025 | -24.35% |
| Jun 30, 2025 | -41.04% |
| Mar 31, 2025 | -50.27% |
| Dec 31, 2024 | -39.49% |
| Sep 30, 2024 | -39.47% |
| Jun 30, 2024 | -29.49% |
| Mar 31, 2024 | -38.92% |
| Dec 31, 2023 | -73.86% |
| Sep 30, 2023 | -78.04% |
| Jun 30, 2023 | -58.35% |
| Mar 31, 2023 | -47.56% |
| Dec 31, 2022 | -32.43% |
| Sep 30, 2022 | -58.21% |
| Jun 30, 2022 | -28.98% |
| Mar 31, 2022 | -12.72% |
| Dec 31, 2021 | -21.58% |
| Sep 30, 2021 | -42.89% |
| Jun 30, 2021 | -2.63% |